MSCA SE CardioSCOPE

MSCA SE CardioSCOPE is at the forefront of revolutionizing cardiovascular health across Europe. By integrating cutting-edge artificial intelligence and multiomics approaches, MSCA SE CardioSCOPE is dedicated to enhancing the understanding and treatment of atherosclerotic cardiovascular disease (ASCVD). With a focus on empowering scientists and advancing research in the 'omics' era, the company is committed to making significant strides in healthcare.

Operating from its primary location in Milan, IT, and with additional locations in Belgrade, RS; Bucharest, RO; Heraklion, GR; Reus, ES; Trento, IT; and London Dairy, GB, MSCA SE CardioSCOPE brings together a network of experts from both academic and corporate sectors. This collaborative environment fosters the exchange and expansion of interdisciplinary expertise in cardiovascular diseases, utilizing a comprehensive multiomic approach.

MSCA SE CardioSCOPE aims to discover novel pathological players, providing deeper insights into ACS development and its progression toward major adverse cardiovascular events (MACE). By employing well-defined prospective cohorts to discover and validate novel genomic, transcriptomic, proteomic, and metabolomic signatures, the company leverages machine learning and AI strategies to deliver more accurate diagnoses and predictions. MSCA SE CardioSCOPE is dedicated to training scientists who are competent for the upcoming ‘omics’ era, ensuring a future of continued innovation and advancement in cardiovascular health. We invite the manager of MSCA SE CardioSCOPE to create a customized and exclusive company showcase and product listing on our platform, further amplifying your reach and impact.